Does EVOLOCUMAB Cause Nasopharyngitis? 2,374 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 2,374 reports of Nasopharyngitis have been filed in association with EVOLOCUMAB (REPATHA). This represents 1.6% of all adverse event reports for EVOLOCUMAB.
2,374
Reports of Nasopharyngitis with EVOLOCUMAB
1.6%
of all EVOLOCUMAB reports
5
Deaths
76
Hospitalizations
How Dangerous Is Nasopharyngitis From EVOLOCUMAB?
Of the 2,374 reports, 5 (0.2%) resulted in death, 76 (3.2%) required hospitalization, and 3 (0.1%) were considered life-threatening.
Is Nasopharyngitis Listed in the Official Label?
Yes, Nasopharyngitis is listed as a known adverse reaction in the official FDA drug label for EVOLOCUMAB.
What Other Side Effects Does EVOLOCUMAB Cause?
Device difficult to use (31,807)
Drug dose omission by device (23,957)
Wrong technique in product usage process (21,664)
Accidental exposure to product (16,160)
Injection site pain (9,988)
Product storage error (6,606)
Back pain (5,254)
Myalgia (5,061)
Drug dose omission (4,914)
Injection site bruising (4,409)
What Other Drugs Cause Nasopharyngitis?
ADALIMUMAB (13,753)
ETANERCEPT (12,421)
METHOTREXATE (8,046)
TOFACITINIB (7,781)
SECUKINUMAB (7,022)
TOCILIZUMAB (6,664)
RITUXIMAB (6,321)
ABATACEPT (6,143)
INFLIXIMAB (5,353)
CERTOLIZUMAB PEGOL (5,295)
Which EVOLOCUMAB Alternatives Have Lower Nasopharyngitis Risk?
EVOLOCUMAB vs EXELON
EVOLOCUMAB vs EXEMESTANE
EVOLOCUMAB vs EXENATIDE
EVOLOCUMAB vs EXFORGE
EVOLOCUMAB vs EXJADE